Position in PFE
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$922,697
-$154,592 QoQ
Shares Held
38,318
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#1,375
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aull & Monroe Investment Management Corp holds $30,785,948 across 9 Drug Manufacturers - General names. PFE ranks #6 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,329 | $11,189,483 | |
| 2 | JNJ |
Johnson & Johnson
|
30,562 | $7,761,831 | |
| 3 | ABBV |
AbbVie Inc.
|
14,519 | $3,653,561 | |
| 4 | AMGN |
Amgen Inc
|
9,494 | $3,437,967 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,386 | $2,362,601 | |
| 6 | PFE |
Pfizer Inc
This page
|
38,318 | $922,697 | |
| 7 | NVS |
Novartis AG
|
3,771 | $590,991 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
9,214 | $530,910 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $922,697 | 38,318 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,077,289 | 38,365 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $982,678 | 39,465 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $987,732 | 38,765 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $976,023 | 40,265 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,174,889 | 46,365 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,289,464 | 48,604 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,571,384 | 54,298 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,564,277 | 55,907 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $1,688,282 | 60,839 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,854,219 | 64,405 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $2,240,965 | 67,560 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,500,108 | 68,160 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $2,801,328 | 68,660 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,596,638 | 70,192 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $3,154,745 | 72,092 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,895,129 | 74,292 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $3,852,516 | 74,416 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $4,409,027 | 74,666 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $3,277,835 | 76,211 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $2,984,422 | 76,211 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $2,715,474 | 74,951 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $2,661,399 | 72,301 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,904,434 | 51,892 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $1,680,520 | 51,392 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $1,719,440 | 52,679 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||